Life Insurance Corporation Of India · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Number of policies sold declined 14.75% YoY to 30.79 lakh, though average ticket size increased 23%. This suggests unit volume weakness that could impact long-term persistency and customer acquisition pipeline. Management attributed this to post-surrender regulation changes but expects agent productivity to improve going forward.
13th month persistency declined to 75.63% from 78.23% and 49th month to 63.45% from 66.97% YoY. This decline was not voluntarily addressed by management in opening remarks, though the appointed actuary noted 13th month persistency improvement is expected to materialize in coming months. Analyst questioned this risk.
Management stated they are evaluating taking a stake in a standalone health insurance company but are awaiting regulatory and statutory changes. No firm timeline or commitment was provided. This delays potential diversification into adjacent health coverage markets.
Government has indicated 2027 timeline for reducing stake to 90%, but management acknowledged they have no direct visibility into government plans. Recent offloading announcement in some tranches is the only update. This leaves potential dilution events unpredictable for investors.
